Clinical Trials
38 trialsCDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Zhejiang University
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
Massachusetts General Hospital
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
Massachusetts General Hospital
MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis
Second Affiliated Hospital of Wenzhou Medical University
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy
Stanford University
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
University of California, Davis
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Colorectal Cancer Legal and Administrative Burden Support: A Pilot Clinical Trial
University of Minnesota
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
Jinling Hospital, China
TF
University Hospital, Lille
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
Fox Chase Cancer Center
A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
Shanghai Changzheng Hospital
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients
Shanghai Changzheng Hospital
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
University of South Florida
FAST-CR
The University of Hong Kong-Shenzhen Hospital
LARC-nCR01
The First Affiliated Hospital with Nanjing Medical University
TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic Cancer
Roswell Park Cancer Institute
68Ga-PMD22 PET/CT Examination Targeting CLDN18.2
Peking Union Medical College Hospital
64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer
Peking Union Medical College Hospital
Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer
Tanta University
NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer
The Third Affiliated Hospital of Guangzhou Medical University
Anesthesia and Postoperative Outcome in Colorectal Cancer Patients
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
Wake Forest University Health Sciences
CRC
Ruijin Hospital
Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer
University of Virginia
Screening for Colorectal Cancer in Average and High Risk Population
Al-Kindy College of Medicine
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
Thomas Jefferson University
The Clinical Application of 68Ga Labeled ssDNA Aptamer Sgc8 in Healthy Volunteers and Colorectal Patients
Xijing Hospital
Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery
University of Oxford
MY-FIT
Kaiser Permanente
General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening
Paris 12 Val de Marne University
Effect of Annona Muricata Leaves on Colorectal Cancer Patients and Colorectal Cancer Cells
Indonesia University
Does Dietary Nitrate Supplementation Improve Aerobic Performance
Royal Surrey County Hospital NHS Foundation Trust
PERFORM
University of Oxford
Information About a Doctor or a Possibility of Choosing Doctor's Gender and Attendance to Screening Colonoscopy
Maria Sklodowska-Curie National Research Institute of Oncology